Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alegro Health vs yourEra

By GLP-1 ScorecardUpdated

Alegro Health
Site position #400

Lower grade

yourEra
Site position #7

Higher grade

Score comparison

yourEra has the higher recorded score — 83.8/100 to 58.9/100.

yourEra grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compounded semaglutide and tirzepatide injections advertised at $89/$129 monthly for new patients, with a named medical practice and three possible pharmacies; confirm the continuing price because homepage and terms differ.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueyourEra +28
54
82
Dose & formulationyourEra +30
52
82
Clinical oversightyourEra +15
70
85
Labs & monitoringyourEra +23
62
85
FulfillmentyourEra +29
57
86
Contract termsyourEra +24
61
85
Alegro Health · top baryourEra · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricAlegro HealthyourEra
WeighScore58.9/10083.8/100
GradeCB
Site position#400#7
Semaglutide$199/mo (starting dose, compounded)$89/mo (new-patient offer; confirm refill terms)
TirzepatideNot disclosed$129/mo (new-patient offer; confirm refill terms)
CoverageCoverage not published50-state clinician network; treatment availability varies by state
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Alegro Health

Site position #400 · C

Strengths

  • Low-cost entry point: 199 dollars for a full 8-week semaglutide starter with B12
  • Direct shipping with no recurring monthly fees
  • Operates from a physical Texas medical practice with a published phone number

What to consider

  • Semaglutide only; no tirzepatide offered
  • Available in select states only, which are not enumerated
  • Thin public information and compounding pharmacy not named on the site
yourEra

Site position #7 · B

Strengths

  • Public new-patient month-to-month prices; advertised same price across doses while active
  • Evaluation, medication, injection supplies, dose management and shipping advertised together
  • Terms name Thryv Telehealth by Lavin, P.C. and three potential dispensing pharmacies
  • Free requested live visit; policy promises full refund if canceled before dispatch

What to consider

  • Compounded formulations are not FDA-approved branded products
  • Homepage price-continuation promise and terms allowing future refill price changes need reconciliation
  • Optimum coaching, nutrition, at-home labs and wearables are coming soon, with no confirmed price or launch date
  • Assessment usually asynchronous; prescription issuance triggers billing, and treatment availability varies by state

Featured provider

yourEra

yourEra scores 83.8/100 (B). Compounded semaglutide and tirzepatide injections advertised at $89/$129 monthly for new patients, with a named medical practice and three possible pharmacies; confirm the continuing price because homepage and terms differ.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard